Press Releases

Jemperli (dostarlimab-gxly) trial continues to show unprecedented results with no evidence of disease in 100% of patients with locally advanced mismatch repair deficient (dMMR) rectal cancer Jun 3, 2024 08:10AM

• Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response
• New treatment options are needed for patients facing negative impacts to quality-of-life with current standard of care
• Additional registrational studies of dostarlimab-gxly in dMMR/microsatellite instability-high rectal (MSI-H) and colorectal cancer are recruiting

PHILADELPHIA--(BUSINESS WIRE)-- GSK plc (LSE/NYSE:... (continue reading...)

Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution for Unmanned Aircraft Systems Jun 3, 2024 08:10AM

The advanced video payload ‎for drones will be based on Maris-Tech’s Uranus technology

Rehovot, Israel, June 03, 2024 (GLOBE NEWSWIRE) -- Maris-Tech Ltd. (Nasdaq: MTEK) ("Maris-Tech" or the "Company"), a B2B provider of edge computing artificial intelligence (“AI”) accelerated video solutions for edge platforms, today announced that it has received an order for $225,000 from Aero Sol, a leading military drone manufacturer, for a new video payload solution... (continue reading...)

Form 8.3 - [KEYWORDS STUDIOS PLC - 31 05 2024] - (CGWL) Jun 3, 2024 08:09AM

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser:CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is... (continue reading...)

Coherent Appoints Jim Anderson as Chief Executive Officer Jun 3, 2024 08:09AM

PITTSBURGH, June 03, 2024 (GLOBE NEWSWIRE) -- Coherent Corp. (the “Company” or “Coherent”) (NYSE: COHR), a global leader in materials, networking, and lasers, today announced that following a comprehensive search, its Board of Directors has appointed Jim Anderson, an established industry executive with a proven track record of driving innovation and leading business transformations, as the Company’s new Chief Executive Officer, effective today. Mr. Anderson... (continue reading...)

Aptevo Participating in the BIO International Convention Jun 3, 2024 08:05AM

SEATTLE, WA / ACCESSWIRE / June 3, 2024 / Aptevo Therapeutics Inc. (Nasdaq: APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR" and ADAPTIR-FLEX" platform technologies, today announced that the Company is participating in the BIO International Convention occurring June 3-6, 2024 in San Diego, CA.

The conference is known for being the largest biotechnology industry conference of the year... (continue reading...)